| Different enantioselective 9-hydroxylation of risperidone by the two human CYP2D6 and CYP3A4 enzymes N Yasui-Furukori, M Hidestrand, E Spina, G Facciolá, MG Scordo, ... Drug Metabolism and Disposition 29 (10), 1263-1268, 2001 | 215 | 2001 |
| Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics N Yasui‐Furukori, T Uno, K Sugawara, T Tateishi Clinical pharmacology & therapeutics 77 (1), 17-23, 2005 | 173 | 2005 |
| Meta-analysis: the effects of smoking on the disposition of two commonly used antipsychotic agents, olanzapine and clozapine Y Tsuda, J Saruwatari, N Yasui-Furukori BMJ open 4 (3), e004216, 2014 | 151 | 2014 |
| Prevalence of perinatal depression among Japanese women: a meta-analysis K Tokumitsu, N Sugawara, K Maruo, T Suzuki, K Shimoda, ... Annals of general psychiatry 19, 1-18, 2020 | 137 | 2020 |
| Metabolism of citalopram enantiomers in CYP2C19/CYP2D6 phenotyped panels of healthy Swedes K Herrlin, N Yasui‐Furukori, G Tybring, J Widén, LL Gustafsson, ... British journal of clinical pharmacology 56 (4), 415-421, 2003 | 136 | 2003 |
| Association of the TaqI A Polymorphism of the Dopamine D2 Receptor Gene With Predisposition to Neuroleptic Malignant Syndrome A Suzuki, T Kondo, K Otani, K Mihara, N Yasui-Furukori, A Sano, ... American Journal of Psychiatry 158 (10), 1714-1716, 2001 | 130 | 2001 |
| Prevalence of metabolic syndrome among patients with schizophrenia in Japan N Sugawara, N Yasui-Furukori, Y Sato, T Umeda, I Kishida, H Yamashita, ... Schizophrenia research 123 (2-3), 244-250, 2010 | 118 | 2010 |
| Mutational analysis of CACNA1G in idiopathic generalized epilepsy B Singh, A Monteil, I Bidaud, Y Sugimoto, T Suzuki, S Hamano, H Oguni, ... Human mutation 28 (5), 524-525, 2007 | 113 | 2007 |
| Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p T Arinami, T Ohtsuki, H Ishiguro, H Ujike, Y Tanaka, Y Morita, M Mineta, ... The American Journal of Human Genetics 77 (6), 937-944, 2005 | 107 | 2005 |
| Relationship between occupational stress and depression among psychiatric nurses in Japan K Yoshizawa, N Sugawara, N Yasui-Furukori, K Danjo, H Furukori, Y Sato, ... Archives of environmental & occupational health 71 (1), 10-15, 2016 | 106 | 2016 |
| Lithium in tap water and suicide mortality in Japan N Sugawara, N Yasui-Furukori, N Ishii, N Iwata, T Terao International journal of environmental research and public health 10 (11 …, 2013 | 98 | 2013 |
| Different inhibitory effect of fluvoxamine on omeprazole metabolism between CYP2C19 genotypes N Yasui‐Furukori, T Takahata, T Nakagami, G Yoshiya, Y Inoue, ... British journal of clinical pharmacology 57 (4), 487-494, 2004 | 97 | 2004 |
| Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia N Yasui-Furukori, H Furukori, N Sugawara, A Fujii, S Kaneko Journal of clinical psychopharmacology 30 (5), 596-599, 2010 | 96 | 2010 |
| Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection T Uno, N Yasui-Furukori, T Takahata, K Sugawara, T Tateishi Journal of pharmaceutical and biomedical analysis 35 (4), 937-942, 2004 | 95 | 2004 |
| The− 141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine … A Suzuki, T Kondo, K Mihara, N Yasui-Furukori, M Ishida, H Furukori, ... Pharmacogenetics and Genomics 11 (6), 545-550, 2001 | 90 | 2001 |
| The effect of aging on the relationship between the cytochrome P450 2C19 genotype and omeprazole pharmacokinetics Y Ishizawa, N Yasui-Furukori, T Takahata, M Sasaki, T Tateishi Clinical pharmacokinetics 44, 1179-1189, 2005 | 89 | 2005 |
| Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome K Mihara, T Kondo, A Suzuki, N Yasui‐Furukori, S Ono, A Sano, K Koshiro, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 117 …, 2003 | 87 | 2003 |
| Significant pharmacokinetic interaction between risperidone and carbamazepine: its relationship with CYP2D6 genotypes S Ono, K Mihara, A Suzuki, T Kondo, N Yasui-Furukori, H Furukori, ... Psychopharmacology 162, 50-54, 2002 | 87 | 2002 |
| Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan N Sugawara, K Danjo, H Furukori, Y Sato, T Tomita, A Fujii, T Nakagami, ... Neuropsychiatric disease and treatment, 779-784, 2017 | 86 | 2017 |
| Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P‐glycoprotein in risperidone disposition T Nakagami, N Yasui‐Furukori, M Saito, T Tateishi, S Kaneo Clinical Pharmacology & Therapeutics 78 (1), 43-51, 2005 | 86 | 2005 |
